KIDNEY CANCER METASTATIC
Clinical trials for KIDNEY CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new KIDNEY CANCER METASTATIC trials appear
Sign up with your email to follow new studies for KIDNEY CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced kidney cancer: first human trial of NEO-811 begins
Disease control Recruiting nowThis early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that has spread or cannot be surgically removed. The goal is to find the safest dose and see how well the drug works. About 30 participants who have already tried other treatme…
Matched conditions: KIDNEY CANCER METASTATIC
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for kidney cancer: targeted pill aims to stop tumor growth
Disease control Recruiting nowThis study tests a daily pill called olaparib in 20 adults with advanced kidney cancer that has spread. To join, your cancer must have a specific gene change (like BAP-1 or BRCA) and you must have already tried at least one other treatment. The goal is to see if olaparib can shri…
Matched conditions: KIDNEY CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New trial aims to boost survival in kidney cancer by combining radiation with drug therapy
Disease control Recruiting nowThis Phase III trial is testing whether adding a precise type of radiation (SBRT) to standard drug therapy (targeted drugs and/or immunotherapy) can help people with kidney cancer that has spread to up to five spots live longer without the disease getting worse. The study will en…
Matched conditions: KIDNEY CANCER METASTATIC
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC